创新的手术方法可以改善晚期乳腺癌患者的个体结果
Valerii Luțenco1, Laura Rebegea2,3, Adrian Beznea1,3
1Surgery I Clinic, Emergency Hospital "Sf. Ap. Andrei", Galați, Romania.
International journal of women's health
|April 5, 2024
概括
乳腺癌的治疗已经进化,新辅助疗法改变了高级病例的手术. 创新的手术方法和重建技术为转移性乳腺癌患者提供了更好的生存率和生活质量.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 乳腺癌是女性癌症死亡的主要原因,其发病率越来越高.
- 晚期呈现在发展中国家很常见,使初始手术管理复杂化.
- 低生存率与短的无病间隔,多个转移部位和肝转移有关.
研究的目的:
- 审查手术在晚期乳腺癌管理中的演变作用.
- 突出新辅助疗法对手术策略的影响.
- 讨论原发性和转移性乳腺癌的创新手术方法.
主要方法:
- 关于高级乳腺癌的手术治疗现有文献的综述.
- 分析新辅助化疗,内分泌疗法和向疗法的整合.
- 对初级瘤和转移性疾病的外科手术方法的检查.
主要成果:
- 新辅助疗法使瘤缩小,将手术意图从缓和转变为治愈.
- 在转移性疾病中治疗原发性瘤的创新手术技术可能会改善存活率和局部控制.
- 对转移部位的外科手术可以改善个体患者的治疗结果.
结论:
- 由于新辅助疗法,手术在晚期乳腺癌中的作用正在扩大.
- 手术管理应该是个性化的,考虑治疗潜力和生存益处.
- 重建性手术的进步改善了患者的生活质量.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


